During the past decade, Eureka Community Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 140 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 27 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eureka Community Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 89 trials, followed by "National Cancer Institute (NCI)" with 61 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eureka Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 148 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Eureka Community Hospital" are "Breast Cancer" (33 trials), "Lung Cancer" (19 trials), "Lymphoma" (18 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "Eureka Community Hospital" in a lesser frequency.

Most popular intervention types in "Eureka Community Hospital" are "Drug" (176 trials), "Other" (90 trials), "Biological" (83 trials), "Radiation" (35 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "placebo" (29 trials), "carboplatin" (18 trials), "Bevacizumab" (17 trials) and "bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Eureka Community Hospital" are 165 trials for "All" genders, 38 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Eureka Community Hospital". undefined are not yet recruiting, undefined are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 149 completed trials in Eureka Community Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Eureka Community Hospital, 14 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".